Altimmune's drug for a type of liver disease shows benefits in mid-stage study
ReutersDec 19, 2025 11:39 AM
Dec 19 (Reuters) - Altimmune ALT.O said on Friday its experimental drug improved signs of liver scarring and liver health after 48 weeks of treatment in a mid-stage study of patients with a serious fatty liver disease known as MASH.
Shares of the company were up 7.3% in premarket trading.
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey
Related Articles
TradingKey 2025 Markets Recap & Outlook | Wall Street Bullish on 2026: S&P 500 Forecast at 8,000 with AI Gains and Cyclical Stocks Soaring
TradingKey - As 2025 draws to a close, the U.S. stock market has delivered a series of exciting and astonishing moments. As 2026 approaches, major Wall Street banks remain confident about the outlook for U.S. equities, with an average forecast for the S&P 500 index reaching 7,500 points.TradingKey
Wed, Dec 24
Ripple Price Prediction: Why Is XRP Price Falling? Can It Rise to $10 in the Future?
XRP has weakened this year due to profit-taking, capital outflows, and its correlation with Bitcoin. Despite support from potential spot ETFs and positive regulatory developments, significant market divergence, liquidity uncertainty, and macroeconomic uncertainty remain high. XRP's price is likely tTradingKey
Wed, Dec 24
Elon Musk’s SpaceX Poised for Record-Breaking IPO: How Can Retail Investors Get In on the Action of Starlink Stock?
TradingKey - Elon Musk's rocket manufacturer SpaceX is expected to launch an IPO in 2026, with a target IPO valuation projected to reach $1.5 trillion. However, prior to its listing, the stock can only be traded in the private market, characterized by low information transparency and high capital baTradingKey
Fri, Dec 19
Gold Price Steady Climb and the Sudden Surge of Silver and Copper: Will Their Bull Run Extend Into 2026?
Dow Jones Market Data shows this marks the first time since 1980all three metals—gold, silver, and copper—simultaneously refreshed their all-time highs in the same year. Will this rally extend into 2026?TradingKey
Wed, Dec 10
Tradingkey
